Sofgen Pharma

Sofgen Pharma EBIT per Share

Delisted·Sep 1, 2026

The EBIT per Share of Sofgen Pharma (PROCF) as of Oct 13, 2026 is -0.29 USD. In the previous year, EBIT per Share was 0.39 USD — a change of -173.36% (lower).

EBIT per Share

-0.29USD

YoY

-173.36%

Last updated:

EBIT per Share of Sofgen Pharma is 2024 -0.29 USD. EBIT per Share of Sofgen Pharma was 2023 0.39 USD. It decreases by -173.36% lower compared to the previous year.

The Sofgen Pharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
0.33 USD
Jan 1, 2020
0.56 USD
Jan 1, 2021
0.58 USD
Jan 1, 2022
0.32 USD
Jan 1, 2023
0.39 USD
Jan 1, 2024
-0.29 USD
The Sofgen Pharma EBIT per Share history
YEAREBIT per ShareYoY
-0.29USD-173.36%
0.39USD+21.91%
0.32USD-44.26%
0.58USD+3.22%
0.56USD+68.72%
0.33USD—
Access this data via the Eulerpool API
Get Free API Key

Sofgen Pharma Stock analysis

What does Sofgen Pharma do? Sofgen Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sofgen Pharma stock

EBIT per Share of Sofgen Pharma is -0.29 USD in 2024.

EBIT per Share of Sofgen Pharma changed from 0.39 USD to -0.29 USD, representing a -173.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Sofgen Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Sofgen Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sofgen Pharma